Results 41 to 50 of about 4,322 (154)

Nocturnal Intraocular Pressure Monitoring With a Soft Contact Lens Sensor for Glaucoma Management

open access: yesAdvanced Materials, Volume 38, Issue 42, 27 July 2026.
A soft contact lens sensor enables continuous, noninvasive monitoring of nocturnal intraocular pressure (IOP) under closed‐eye sleep conditions. By integrating a highly compliant inductive–capacitive circuit onto a commercial lens, the device achieves record sensitivity and stable performance.
Yumin Dai   +19 more
wiley   +1 more source

Comparative study of brimonidine and timolol in treatment of glaucoma

open access: yesMRIMS Journal of Health Sciences, 2015
Background: As population is affected with primary open angle Glaucoma is large. It is important to evaluate drugs which effectively control the intraocular pressure.
Jagadish Chandrarao Narasaiah Lakkineni
doaj   +1 more source

Brimonidine tartrate effect on retinal spreading depression depends on Müller cells

open access: yesRevista Brasileira de Oftalmologia, 2014
Objective: Demonstrate the Brimonidine effect over Retinal Spreading Depression (SD). Brimonidine is an alpha-2–adrenergic receptor agonist, used in the management of glaucoma. Alpha2-agonists have been shown to be neuroprotective in various experimental
Vinícius Vanzan Pimentel de Oliveira   +5 more
doaj   +1 more source

Emerging Medications in Facial Nerve Recovery: A Systematic Review and Meta‐Analysis

open access: yesOTO Open, Volume 10, Issue 3, July-September 2026.
Abstract Objective To systematically review the literature for medical therapies that promote facial nerve regeneration and recovery. Data Sources PubMed/Medline, Embase, and SCOPUS databases were searched for English‐language studies published from inception through May 2025.
Kimberly Chan   +5 more
wiley   +1 more source

Global scope of glaucoma clinical practice for optometrists

open access: yesOptometry and Vision Science, Volume 103, Issue 7, July 2026.
ABSTRACT Purpose The role of optometrists in glaucoma care is evolving rapidly in many parts of the world. This review aims to describe the current global scope of clinical practice for optometrists with respect to glaucoma, highlighting progress and identifying barriers to care across diverse regions.
Jonathan Denniss   +9 more
wiley   +1 more source

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

open access: yesChemistry Central Journal, 2017
Background A simple, rapid and accurate stability-indicating reverse phase high performance liquid chromatography (RP-HPLC) was developed and validated for the determination of brimonidine tartrate in brimonidine tartrate/poly(2-hydroxyethyl methacrylate)
Jianguo Sun, Xiuwen Zhang, Taomin Huang
doaj   +1 more source

Prophylactic effect of brimonidine to minimize the incidence of subconjunctival hemorrhage in the early postoperative period after 23G pars plana vitrectomy

open access: yesTherapeutic Advances in Ophthalmology, 2021
Background: Several studies have investigated and demonstrated the prophylactic effect of brimonidine drops in preventing subconjunctival hemorrhage in some microincisional ophthalmic surgeries, such as intravitreal injections or cataract surgery ...
Mari Carmen Desco   +7 more
doaj   +1 more source

Dual‐Responsive Chitosan‐Grafted PNIPAAm Hydrogel Eye Drop Incorporating Insulin‐Imprinted Microgels for Dry Eye Syndrome Treatment

open access: yesMacromolecular Bioscience, Volume 26, Issue 6, June 2026.
ABSTRACT Dry eye syndrome (DES) happens as a result of inadequate tear secretion or excessive evaporation, which leads to ocular surface irritation and damage. A major therapeutic challenge is maintaining effective drug concentrations, as topical formulations are rapidly cleared by blinking and tear turnover.
Masoumeh Alsadat Hosseini   +6 more
wiley   +1 more source

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy